Issue 5, 2014

Recent trends in the design of anticancer polymer prodrug nanocarriers

Abstract

Nanocarriers based on polymers have attracted much attention to perform drug delivery, especially in cancer therapy. Although significant advances have been reported, important obstacles still remain with the use of encapsulated anticancer drugs in polymer nanoparticles (e.g., ‘burst release’, poor drug loading, low miscibility of certain drugs with the polymer matrix). To solve these issues, synthetic strategies orientated toward the prodrug approach, whereby the drug is covalently linked to the polymer scaffold, have been investigated and are detailed in the present review. It will focus on recent synthetic strategies to achieve drug–polymer conjugate nanoassemblies as well as their biological evaluations.

Graphical abstract: Recent trends in the design of anticancer polymer prodrug nanocarriers

Article information

Article type
Review Article
Submitted
02 Oct 2013
Accepted
25 Oct 2013
First published
29 Oct 2013

Polym. Chem., 2014,5, 1529-1544

Recent trends in the design of anticancer polymer prodrug nanocarriers

V. Delplace, P. Couvreur and J. Nicolas, Polym. Chem., 2014, 5, 1529 DOI: 10.1039/C3PY01384G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements